Serum levels of the low-affinity interleukin-2 receptor molecule (TAC) during IL-2 therapy reflect systemic lymphoid mass activation

Stephan D. Voss, Jacquelyn A. Hank, Catherine A. Nobis, Paul Fisch, Jeff A. Sosman, Paul M. Sondel*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint Dive into the research topics of 'Serum levels of the low-affinity interleukin-2 receptor molecule (TAC) during IL-2 therapy reflect systemic lymphoid mass activation'. Together they form a unique fingerprint.

Medicine & Life Sciences